SAN DIEGO, July 11 /PRNewswire-FirstCall/ -- PURE Bioscience (Nasdaq: PURE) announced today that Michael L. Krall, the company's president and CEO, is scheduled to ring the closing bell at the NASDAQ Stock Exchange at 4:00 PM on Tuesday, July 15, 2008, to commemorate PURE's return to the NASDAQ stock market on April 2, 2008.
A live webcast of the closing ceremony will begin at 3:50 PM and can be viewed via The MarketSite Webcam by launching this link: http://www.nasdaq.com/about/marketsitetowervideo.asx.
Earlier this month, PURE entered into an agreement with FTA Therapeutics, LLC for the development and licensing of silver dihydrogen citrate (SDC)-based products for clinical projects for FDA-regulated dermatology, wound care and medical biofilm control products. In April, PURE announced a partnership with Rockline Industries Inc, for North American distribution of PURE's ready-to-use "Powered by SDC" disinfectant product and for the development and North American distribution of wipes products, as well as new disinfectant, sanitizer and preservative products containing the company's patented antimicrobial, silver dihydrogen citrate (SDC).
"Powered by SDC(TM)"
SDC, PURE Bioscience's flagship technology, is the first new
disinfectant active to be registered by the EPA in more than 30 years, and
"Powered by SDC" disinfectants combine extraordinary broad spectrum
antimicrobial action with a previously unattainable safety profile. SDC is
a patented, aqueous non-toxic antimicrobial, which is an electrolytically
generated source of stabilized ionic silver that can serve as the basis for
a broad range of products in diverse markets. PURE also manufactures and
sells varying strengths of SDC concentrate as
|SOURCE PURE Bioscience|
Copyright©2008 PR Newswire.
All rights reserved